Panel 1
Thailand have achieved notable success in its commitment in ensuring that Thai citizens not only gain access to care, but also affordable care. Within two decades since its healthcare reform in 2002, Universal Coverage Health Scheme (UCHS) have enabled 99.5% of its population to enjoy free healthcare. Its achievements in healthcare provision have enabled Thailand to be crowned as the model of best practice for emerging nations to learn from.
While Thailand has excelled in providing healthcare coverage and increasing health literacy for its citizens, there remains aspects within the community that needs to be addressed before it can be fully classed as a health-inclusive society. The unequal distribution of health resources in geographically remote locations; developing a patient-centric healthcare system, and; caring after the neglected needs of its senior citizens, are some examples. This is where the Ministry of Public Health can partner with private stakeholders and leverage on existing outreach programmes and initiatives to care for the needs of the most vulnerable groups within the Thai communities. In addressing the existing gaps within the healthcare system, Thailand can continuously promote better health and better life for its citizens, giving Thais more reasons to smile, than one.
In this panel, the various stakeholders will discuss the following:
Panel 2
With greater access and affordability to care, Thais are generally living longer. This is evident with an improvement in two-year survival rates for cancer and cardiac arrest. Yet, the incidence of cancer in Thailand remains high; and the country remains to have the highest prevalence of HIV across Southeast Asia, despite significant advances in its management. Over half of new HIV cases in Thailand are from key populations, thus innovative and effective strategies are needed to enhance the Recruit-Test-Treat-Prevent-Retain cascade for HIV prevention and care. For Liver cancer, otherwise known as Hepatocellular Carcinoma (HCC), it is identified to be the leading cancer in males and the third in frequency in females.
While vaccines and behavioural determinants play a major role in primary prevention, diagnostics and screening is pivotal in secondary and tertiary prevention. Especially critical is the role of diagnostics in detecting, managing, and treating both HCC and HIV. By developing diagnostics capability and encouraging the uptake of early screening, patients can benefit from curative care. Mortality rates from HCC can decrease by as much as 37%; annual new infections of HIV can also witness a reduction through routine screening and dedicated public health interventions. There are merits to diagnostics and screening. Enabling timely intervention and early treatment to increase survival rates of patients are just some of them.
In this session, the experts will share on the following:
Deputy Secretary-General at National Health Security Office
General Manager Thailand at Haleon
Head of Corporate Affairs, Wider Asia at Haleon
Senior Brand Manager at Haleon
National Expert Sales Manager at Haleon
Head of prosthodontic department, Department of Prosthodontics at Faculty of Dentistry
President at Thai Pharmacist Association
Managing Director of Zuellig Pharma Thailand
Head of Corporate Affairs, Wider Asia at Haleon
Executive Director of EU-ASEAN Business Council
Permanent Secretary at Ministry of Public Health
Country Director of UNFPA, Thailand
GM at Roche Diagnostics Thailand
Head of Marketing & Business Development at Abbott
MD, Head of Division of Gastroenterology, Faculty of Medicine Siriraj Hospital at Mahidol University
Deputy Director of Bureau of AIDS TB and STIs Thailand
Department of Disease Control, Thailand Ministry of Public Health at US-CDC Collaboration
Executive Director of EU-ASEAN Business Council